Baraliakos X, et al. Long-Term Evaluation of Secukinumab in Ankylosing Spondylitis: 5 Year Efficacy and Safety Results from a Phase 3 Trial. ACR 2018, abstract L13.
NERASS Najaarscongres: 'What’s new in CRPS & OA'
jan 2019 | Artrose
nov 2022 | Psoriasis
nov 2020
okt 2020
aug 2020 | RA, SLE